Differential impact of rheumatoid factor levels on biologic persistence in rheumatoid arthritis: non-TNF inhibitors versus certolizumab pegol (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2423; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
|
|
Sara Salas Santamaria, MD
|